What does PHARMANET do?

PHARMANET is a logistics company in Frameries. Public Limited, started on 29 November 1984, 3 establishments.

What is the address of PHARMANET?

The registered office of PHARMANET is located at Rue Montavaux 155, 7080 Frameries.

Is PHARMANET still active?

Yes. According to the CBE (30 October 2026) PHARMANET is active, legal situation “Normale toestand”, started on 29 November 1984.

Is PHARMANET registered on Peppol?

Yes, PHARMANET is registered on the Peppol network with ID 0208:0426485640.

What is the enterprise number of PHARMANET?

The enterprise number of PHARMANET is BE0426485640.

When was PHARMANET founded?

PHARMANET was founded on 29 November 1984.

Who are the directors of PHARMANET?

According to the 2025 annual accounts, the directors of PHARMANET are: GEORGES BEAUJEAN, FINPHARMA SA, PIERRE PASCAL HECQ.

Is PHARMANET a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 November 1984; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account; 3 establishments in the CBE.

How much profit did PHARMANET make in 2025?

PHARMANET posted a profit after taxes of € 134,339 in financial year 2025.

What is the revenue of PHARMANET?

As a small company, PHARMANET is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 401,485.

PHARMANET (Public Limited) - Frameries - BE0426485640

Dossier PHARMANET, printed on 30 October 2026 from databakkes.be/en/0426485640/pharmanet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

22 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

PHARMANET from Frameries, company number BE0426485640, closed financial year 2025 with a result of € 134,339 after tax. For that financial year PHARMANET recorded a gross margin of € 401,485 and equity of € 416,222. Compared with financial year 2024, the result moved from € 101,552 to € 134,339. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 416,222

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 134,339

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 507,169

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

74 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 249,756

▲ 27% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes and wages

€ 63,665

▲ 35% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 382,939 Gross margin 2022: € 382,939 First fiscal year in the series	€ 392,082 Gross margin 2023: € 392,082 ▲ 2% vs 2022 (€ 382,939) Favourable step	€ 361,150 Gross margin 2024: € 361,150 ▼ 8% vs 2023 (€ 392,082) Unfavourable step	€ 401,485 Gross margin 2025: € 401,485 ▲ 11% vs 2024 (€ 361,150) Favourable step	▲ 11%
Profit after taxes	€ 140,018 Profit after taxes 2022: € 140,018 First fiscal year in the series	€ 123,332 Profit after taxes 2023: € 123,332 ▼ 12% vs 2022 (€ 140,018) Unfavourable step	€ 101,552 Profit after taxes 2024: € 101,552 ▼ 18% vs 2023 (€ 123,332) Unfavourable step	€ 134,339 Profit after taxes 2025: € 134,339 ▲ 32% vs 2024 (€ 101,552) Favourable step	▲ 32%
Equity	€ 556,999 Equity 2022: € 556,999 First fiscal year in the series	€ 380,331 Equity 2023: € 380,331 ▼ 32% vs 2022 (€ 556,999) Unfavourable step	€ 381,883 Equity 2024: € 381,883 Unchanged (€ 380,331) Favourable step	€ 416,222 Equity 2025: € 416,222 ▲ 9% vs 2024 (€ 381,883) Favourable step	▲ 9%
Total debts	€ 448,170 Total debts 2022: € 448,170 First fiscal year in the series	€ 350,985 Total debts 2023: € 350,985 ▼ 22% vs 2022 (€ 448,170) Favourable step	€ 147,465 Total debts 2024: € 147,465 ▼ 58% vs 2023 (€ 350,985) Favourable step	€ 163,665 Total debts 2025: € 163,665 ▲ 11% vs 2024 (€ 147,465) Unfavourable step	▲ 11%
Cash	€ 939,576 Cash 2022: € 939,576 First fiscal year in the series	€ 483,695 Cash 2023: € 483,695 ▼ 49% vs 2022 (€ 939,576) Unfavourable step	€ 443,420 Cash 2024: € 443,420 ▼ 8% vs 2023 (€ 483,695) Unfavourable step	€ 507,169 Cash 2025: € 507,169 ▲ 14% vs 2024 (€ 443,420) Favourable step	▲ 14%
Retained profit	€ 382,699 Retained profit 2022: € 382,699 First fiscal year in the series	€ 206,031 Retained profit 2023: € 206,031 ▼ 46% vs 2022 (€ 382,699) Unfavourable step	€ 207,583 Retained profit 2024: € 207,583 ▲ 1% vs 2023 (€ 206,031) Favourable step	€ 241,922 Retained profit 2025: € 241,922 ▲ 17% vs 2024 (€ 207,583) Favourable step	▲ 17%
Dividend	€ 400,000 Dividend 2022: € 400,000 First fiscal year in the series	€ 300,000 Dividend 2023: € 300,000 ▼ 25% vs 2022 (€ 400,000) Unchanged	€ 100,000 Dividend 2024: € 100,000 ▼ 67% vs 2023 (€ 300,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 Unchanged (€ 100,000) Unchanged
Balance sheet total	€ 1,005,169 Balance sheet total 2022: € 1,005,169 First fiscal year in the series	€ 731,316 Balance sheet total 2023: € 731,316 ▼ 27% vs 2022 (€ 1,005,169) Unchanged	€ 529,348 Balance sheet total 2024: € 529,348 ▼ 28% vs 2023 (€ 731,316) Unchanged	€ 579,887 Balance sheet total 2025: € 579,887 ▲ 10% vs 2024 (€ 529,348) Unchanged	▲ 10%

Key figures of PHARMANET, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMANET?

What happened at PHARMANET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 GEORGES BEAUJEAN stepped down as director. NBB
2028 FINPHARMA SA stepped down as director. NBB
2028 PIERRE PASCAL HECQ stepped down as director. NBB
Jun 30, 2026 New annual accounts for financial year 2025: profit of € 134,339 (▲ 32% vs 2024). Source: NBB ↗
2022 GEORGES BEAUJEAN became a director. NBB
2022 FINPHARMA SA became a director. NBB
2022 PIERRE PASCAL HECQ became a director. NBB
Jun 26, 2003 New establishment in Etterbeek. KBO

In short

From € 140,018 profit in 2022 to € 134,339 profit in 2025.

Best year ever: 2022, with € 140,018 profit.

Paid out € 900,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

GEORGES BEAUJEAN

Director

since 2022 · until 2028

FINPHARMA SA

Director · represented by PHILIPPE BOULANGER

Also active at: Les Pharmacies Réunies, P.J. VLEUGELS et Cie, GESTIPHARMA, FINANCIERE DU LOUVY, GERPINNES PHARMA

since 2022 · until 2028

PIERRE PASCAL HECQ

Managing director

Also active at: Les Pharmacies du Louvy, FARMIMMO, IMMOBILIERE DES QUATRE SEIGNEURIES, PHARMACIE RONDEAU, GERPINNES PHARMA, Pharmacie de la Chasse Royale, OBIPHAR

since 2022 · until 2028

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Montavaux 155

7080 Frameries

2.025.811.049

Rue Montavaux sn

7080 Frameries

Active since 7 December 1984

2.132.432.063

Oudergemlaan 261

1040 Etterbeek

Active since 26 June 2003

2.252.323.172

Route de Philippeville 463

6010 Charleroi

Active since 1 January 2003

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 22 companies are registered at this address.

All companies at this address →

Les Pharmacies Réunies same network

€ 22,093 gross margin · 2025

Immobilière Général Léman

€ 92,019 gross margin · 2025

P.J. VLEUGELS et Cie same network

€ 132,509 gross margin · 2025

EVRAS

€ 47,127 gross margin · 2025

Pharmacie Grenez - Seeuws

€ 16,802 gross margin · 2025

+17 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.485.640

VAT number

BE 0426.485.640

Registered office

Rue Montavaux 155, 7080 Frameries

Names & denominations

PHARMANET

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

29 November 1984

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Discotheken, dancings en dergelijke

Activiteiten van eetgelegenheden met beperkte bediening, muv mobiele eetgelegenheden

Fastfoodzaken, snackbars, frituren en dergelijke

Eetgelegenheden met beperkte bediening

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMANET

Warning lights

Financials

What happened to PHARMANET?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions